INTRODUCTION {#sec1-1}
============

Smoking is a big ongoing hazard for humanity and regarded as an important risk factor for chronic obstructive pulmonary disease (COPD) and other systemic dysfunctions.\[[@ref1][@ref2]\] Nearly 33%--35% people die in India because of smoking for 15 years continuously.\[[@ref3]\]

COPD is the fourth most conjoint reason of death in the world, and its liability has increased, due to unceasing risk of respiratory diseases and modifications in lifestyle.\[[@ref4][@ref5]\] In this era of modern technology, it is preferable to diagnose COPD at an earlier stage and to observe its progression so that mortality and morbidity of the disease could be reduced. For diagnosing COPD, spirometry is the gold standard but early detection of minute changes in airway conduction is not possible. This drawback can be overcome with body plethysmography, especially in smokers.\[[@ref6][@ref7]\]

Hence, we led this study to evaluate parameters of body plethysmography in Indian population where the data are lacking. We also would like to assess the use of body plethysmography for early detection of COPD and changes in its values in mild, moderate, and severe COPD (C1, C2, and C3, respectively).

SUBJECTS AND METHODS {#sec1-2}
====================

The study was accepted by the Ethical Committee at B. J Government Medical College, Pune, (Maharashtra) India. In this comparative randomized cross-sectional study, healthy control subjects (CN), smokers without COPD diagnosis (SM) who had smoked at least 5 pack-years, and smokers with COPD categorized as mild COPD (C1), moderate COPD (C2), and severe COPD (C3) depending on GOLD criteria\[[@ref8]\] (*n* = 30 each group) were considered. Participants were selected by simple randomization to avoid selection bias. All the participants were in the age group of 35--60 years were males, and those who provided written informed consent for performing spirometry and body plethysmography were considered for the study. Screening test was performed for willing participants to categorize them under CN, SM, and COPD patients, for which the following criteria were considered for inclusion and exclusion of participants.

For inclusion of controls {#sec2-1}
-------------------------

No past or present history of COPD or any other respiratory diseaseParticipants with no present or past history of smokingNormal spirometry.

For inclusion of smokers without chronic obstructive pulmonary disease {#sec2-2}
----------------------------------------------------------------------

A smoker without any symptoms of respiratory diseases or diagnosed COPDParticipants smoking at least 5 pack-years.

For inclusion of chronic obstructive pulmonary disease patients {#sec2-3}
---------------------------------------------------------------

Smoking \>5 pack-yearsDiagnosed cases of COPD with FEV~1~\< 70% as per GOLD guidelines for COPD\[[@ref8]\]No exacerbation of COPD in past 1 month or history of hospitalization for COPD within past 3 months4. Able to cooperate and perform spirometry and body plethysmography.

Exclusion criteria {#sec2-4}
------------------

FEV~1~/FVC \<30% On spirometry or COPD requiring hospitalizationUnstable or high-risk patients unable to perform spirometry or body plethysmographyKnown cases of ischemic heart disease, heart failure, atrial fibrillation, hypertension, or any electrocardiographic abnormalityPatients in need of long-term oxygen therapy.

Flow chart for selection of participants {#sec2-5}
----------------------------------------

Three hundred and fifty participants selected for study, of which 200 selected by simple randomization of odd and even number technique and 50 were excluded as per the exclusion criteria.

Spirometry and body plethysmography were performed according to established protocol at the time of visit after a week of screening avoiding their morning medications.\[[@ref9][@ref10]\]

Body plethysmography is used for the purpose of computing total lung capacity (TLC) and airway conductance (Gaw). During body plethysmography, the participant was asked to sit in a chamber prepared to measure pressure and flow or volume changes \[[Figure 1](#F1){ref-type="fig"}\]. Airways resistance (Raw) could also be calculated as the inverse of Gaw. Specific airway conductance (sGaw)(that is conductance/unit of lung volume) was reported as sGaw in L/s/cmH~2~O (Liter per se cond per centimeter of water). For measuring sGaw dynamic pressure, flow volume type plethysmograph; CRF Master Screen Body Diff., JAEGER Hochberg, Germany was used.

![Participant performing body plethysmography](LI-35-127-g001){#F1}

With spirometry FEV~1~, FVC in liters (L) FEV~1~/FVC in percentage and FEF~25-75%~, and PEFR in liters/second (L/s) parameters were recorded by the following ATS/ERS guidelines.\[[@ref10]\] With body plethysmography, sGaweff, sGawtot in L/s/cm H~2~O, and inspiratory capacity (IC), residual volume (RV), and TLC in liters (L) were recorded. The differences in lung function were compared among these groups using analysis of variance and Bonferroni\'s *post hoc* test.

RESULTS {#sec1-3}
=======

In present study, males of similar age group with no demographical differences were discovered; hence, all the groups are comparable, details are as given in [Table 1](#T1){ref-type="table"}.

###### 

Demographic values of subjects (mean±standard deviation)

![](LI-35-127-g002)

Results of spirometry and body plethysmography are depicted in Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}, respectively.

###### 

Spirometry parameter values (mean±standard deviation)

![](LI-35-127-g003)

###### 

Body plethysmography parameters values (mean±standard deviation)

![](LI-35-127-g004)

[Table 4](#T4){ref-type="table"} summarizes that results of differences in lung function were compared among the three groups using univariate ANOVA and Bonferroni\'s *post hoc* test.

###### 

Analysis of variance and Bonferroni\'s *post hoc* results

![](LI-35-127-g005)

The difference in mean values of FEV~1~, FVC, FEV~1~/FVC%, FEF~25-75%~, and PEFR by spirometry were not significant in smokers without COPD and normal healthy controls. Intergroup changes were not significantly different in spirometry parameters.

Mean values of IC, sGawtot, and sGaweff values were assessed by body plethysmography, which showed significant differences among smokers without COPD and normal healthy controls. TLC, RV, IC, sGawtot, and sGaweff showed significant changes in intergroup analysis.

DISCUSSION {#sec1-4}
==========

For uncovering changes in pulmonary function test, spirometry is generally used. However, spirometry has its own limitations for the early detection of COPD. Hence, more advanced techniques such as body plethysmography can be used. Body plethysmography gives us idea about Gaw and TLC which are supposed to be more sensitive and specific for revealing the changing form in airways causing diseases.\[[@ref11]\]

In the present study, we observe that FEV~1~, FEV~1~/FVC, and FEF~25-75%~ values were not significantly different between healthy controls (CN) and smokers without COPD (SM). We observed three parameters in body plethysmography (IC, sGawtot, and sGaweff) were sensitive enough to detect early lung injury that spirometry was unable to detect \[[Table 4](#T4){ref-type="table"}\].

As in the present study, age-matched males are taken in consideration fall in FEV~1~ is attributed to smoking causing increased mucus secretion but to diagnose early COPD more advanced techniques should also be considered.\[[@ref12][@ref13][@ref14]\]

de Mir Messa *et al*. had shown that sensitivity of lung conductance parameters (sGawtot and sGaweff) is more for knowing the changes in airway caliber causing obstructive lung diseases when compared with spirometry parameters. Similar results were observed in the present study when healthy control (CN) compared with smokers without COPD (SM).\[[@ref15]\]

As far as IC values were concerned, similar results were observed by Houghton *et al*., they established that IC goes on decreasing due to increased resistance offered by airway passage with the advancement of disease. Moreover, similar changes can also be observed in other parameters of body plethysmography specifically related to conductance.\[[@ref16]\]

According to Reilly in COPD patients, there is increased residual air inside lungs, loss of elastic recoil of lung parenchyma, and there is decreased Gaw. All of these contribute in augmented work of breathing. Increased work will give load on active processes of respiration that is inspiration. This may lead to a reduction in volume of air entering lungs clarifying fall in IC. These findings could be attributed to mechanisms mentioned.\[[@ref17]\]

Borrill studied effect of bronchodilator drugs in smokers without COPD, severe COPD, and controls by measuring Gaw and concluded that sGaw values can sensitively differentiate between different drug effects as compared to spirometric parameters. At the same time, they also stated that sGaw values were progressively lower in smokers and COPD. This observation goes in line with the present study.\[[@ref18]\]

Considering spirometry and body plethysmography results, similar results were found by Thomas R Gildea and they stated that with spirometry, there are limitations as it cannot measure RV, FRC, and TLC but with body plethysmography in addition to these parameters other parameters such as sGawtot and sGaweff can also be measured which can give comprehensive evaluation of COPD for early diagnosis, progression, and assessment of severity of disease.\[[@ref19]\]

Hence, if these smokers refrained from smoking, then there will be reduction in the rate of damage to the lungs. Hence, the early detection of changes in pulmonary function test is possible which will reduce morbidity and mortality.

CONCLUSION {#sec1-5}
==========

It can be concluded that body plethysmographic parameters such as IC, sGawtot, and sGaweffare of importance to identify the participants early in the course of their disease at a stage where the present guidelines using spirometry are unable to detect any change and further studies are required in the Indian population to assess whether they are good predictors of progression of disease, prognosis, and disease severity.

If it is possible to detect these participants who smoke early in the course of their disease, smoking cessation may reduce the rate of lung damage. Studies need to confirm whether this has a role in halting further progression into COPD and potentially could have a significant benefit in reducing morbidity and mortality due to COPD.

However, there are very few studies emphasizing the importance of body plethysmography, especially in India. This could be due to lack of awareness or lack of infrastructure. The finding of the present study can be a stepping stone toward more research on the assessment of pulmonary function tests with body plethysmography. It can lay a foundation for early detection of various respiratory disorders.
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